Amneal Pharmaceuticals, Inc. (AMRX)
16.65
-0.57
(-3.31%)
USD |
NASDAQ |
Sep 15, 16:00
16.64
-0.01
(-0.06%)
Pre-Market: 20:00
Amneal Pharmaceuticals Price to Book Value : 160.99 for Sept. 15, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 15, 2026 | 160.99 |
| September 14, 2026 | 166.51 |
| September 11, 2026 | 164.48 |
| September 10, 2026 | 163.12 |
| September 09, 2026 | 166.80 |
| September 08, 2026 | 164.86 |
| September 04, 2026 | 168.63 |
| September 03, 2026 | 172.79 |
| September 02, 2026 | 174.63 |
| September 01, 2026 | 170.95 |
| August 31, 2026 | 168.92 |
| August 28, 2026 | 169.60 |
| August 27, 2026 | 174.14 |
| August 26, 2026 | 173.95 |
| August 25, 2026 | 173.27 |
| August 24, 2026 | 171.92 |
| August 21, 2026 | 173.18 |
| August 20, 2026 | 173.08 |
| August 19, 2026 | 175.11 |
| August 18, 2026 | 175.88 |
| August 17, 2026 | 178.11 |
| August 14, 2026 | 175.50 |
| August 13, 2026 | 166.99 |
| August 12, 2026 | 170.76 |
| August 11, 2026 | 165.35 |
| Date | Value |
|---|---|
| August 10, 2026 | 172.89 |
| August 07, 2026 | 175.40 |
| August 06, 2026 | 174.72 |
| August 05, 2026 | 178.50 |
| August 04, 2026 | 178.69 |
| August 03, 2026 | 182.27 |
| July 31, 2026 | 177.14 |
| July 30, 2026 | 178.88 |
| July 29, 2026 | 184.68 |
| July 28, 2026 | 181.40 |
| July 27, 2026 | 174.92 |
| July 24, 2026 | 173.27 |
| July 23, 2026 | 173.76 |
| July 22, 2026 | 171.63 |
| July 21, 2026 | 175.01 |
| July 20, 2026 | 169.21 |
| July 17, 2026 | 172.60 |
| July 16, 2026 | 174.43 |
| July 15, 2026 | 166.31 |
| July 14, 2026 | 161.38 |
| July 13, 2026 | 166.12 |
| July 10, 2026 | 164.48 |
| July 09, 2026 | 164.57 |
| July 08, 2026 | 163.99 |
| July 07, 2026 | 164.86 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Liquidia Corp. | 30.01 |
| Eli Lilly & Co. | 31.57 |
| Viatris, Inc. | 1.349 |
| Harmony Biosciences Holdings, Inc. | 2.453 |
| ANI Pharmaceuticals, Inc. | 2.774 |
Price to Book Value Related Metrics
| PE Ratio | 34.75 |
| PS Ratio | 1.749 |
| PEG Ratio | 0.0046 |
| Price | 16.65 |
| Earnings Yield | 2.88% |
| Market Cap | 5.317B |
| PEGY Ratio | 0.0046 |
| Operating PE Ratio | 11.43 |
| Normalized PE Ratio | 26.80 |